Justin Lieblong, MD
Ophthalmology · Little Rock, ARNPI 1427215623
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,539 of the $2,327 with a category attached, or 66.2%. Alcon accounts for 75.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $1,129 and has fallen 84.8% since, to $172 in 2025.
Across 58 payments — averaging $40.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- AbbVie$188
- Carl Zeiss Meditec USA, Inc.$138
- Bausch & Lomb Americas Inc.$47
- Eyevance Pharmaceuticals LLC$40
- Novartis$38
- plus $123 from 6 others
What the payments were for
- Travel & lodging$76833%
- Food & beverage$1,53966%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 36 | $1,754 |
| AbbVie(2 entities) | 8 | $188 |
| Carl Zeiss Meditec USA, Inc. | 1 | $138 |
| Bausch & Lomb Americas Inc. | 3 | $47 |
| Eyevance Pharmaceuticals LLC | 2 | $40 |
| Novartis | 2 | $38 |
| Carl Zeiss Meditec, Inc. | 1 | $33 |
| Kala Pharmaceuticals, Inc. | 1 | $24 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Sight Sciences, Inc. | 1 | $19 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $15 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IOLMaster 700$138
- ARGOS$136
- ORA$131
- Clareon$120
- Clareon PanOptix Pro$120
- SIMBRINZA$104
- Rocklatan$104
- Rhopressa$104
How this compares
$2,327 in reported general payments places this provider in the 80th percentile of 125 ophthalmology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lotemax SmLoteprednol Etabonate | 119 | $30,046 |
| ProlensaBromfenac Sodium | 40 | $13,728 |
| LumiganBimatoprost | 37 | $10,268 |
| Bromfenac Sodium | 51 | $9,475 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 194 | $1,271 |
| Timolol Maleate | 36 | $619 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 40 | $528 |
| Latanoprost | 36 | $332 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm, Prolensa | $15 | $43,774159 claims |
| AbbVieLumigan | $188 | $10,26837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 125 ophthalmology providers in Arkansas.
Other ophthalmology in Little Rock
- Jennifer DoyleLittle Rock$38K
- Jonathan CascianoLittle Rock$4K
- Christian HesterLittle Rock$4K
- Sami UwaydatLittle Rock$4K
- Daniel KimLittle Rock$2K
- Kent ZocchiLittle Rock$2K
- Lydia LaneLittle Rock$2K
- Richard MorshediLittle Rock$2K
- Susan BlairLittle Rock$2K
- Tom KornhauserLittle Rock$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.